A detailed history of Aia Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Aia Group LTD holds 47,934 shares of ABBV stock, worth $9.25 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
47,934
Previous 43,995 8.95%
Holding current value
$9.25 Million
Previous $8.01 Million 2.62%
% of portfolio
0.25%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $609,717 - $712,013
3,939 Added 8.95%
47,934 $8.22 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $5.16 Million - $5.88 Million
32,295 Added 276.03%
43,995 $8.01 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $481,462 - $542,240
3,499 Added 42.67%
11,700 $1.81 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $1.1 Million - $1.27 Million
8,201 New
8,201 $1.22 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $571,354 - $657,999
-3,951 Reduced 12.32%
28,131 $4.48 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $2.11 Million - $2.53 Million
15,249 Added 90.59%
32,082 $5.19 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $2.22 Million - $2.55 Million
-16,569 Reduced 49.6%
16,833 $2.26 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $784,296 - $997,097
5,699 Added 20.57%
33,402 $5.12 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $215,127 - $266,912
-1,630 Reduced 5.56%
27,703 $4.49 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $2.34 Million - $2.96 Million
21,791 Added 288.93%
29,333 $3.97 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $716,391 - $813,211
-6,733 Reduced 47.17%
7,542 $814,000
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $357,293 - $398,045
3,396 Added 31.22%
14,275 $1.65 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $457,690 - $503,861
4,474 Added 69.85%
10,879 $1.18 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $515,538 - $696,031
6,405 New
6,405 $685,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aia Group LTD Portfolio

Follow Aia Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.